Mature B-Cell Non-Hodgkin Lymphoma — Trials

Mature B-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

2,506 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 792
Recruiting: 401
Ph III recruiting: 40
Growth YoY: +8%
Industry share: 24%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (393)

clinicaltrialsPublishedShowing 451–500 of 514 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05281809	Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia	recruiting	Phase 2	30	John ListerOTHER	1	Jan 13, 2025	clinicaltrials
NCT06757894	Efficacy and Safety of Zuberitamab Combined with Bendamustine, Followed by Monotherapy Maintenance, in Treatment-naïve Follicular Lymphoma	not yet recruiting	Phase 2	50	Sun Yat-sen UniversityOTHER	1	Jan 3, 2025	clinicaltrials